Latest News

Alexion and DHL sign Ireland’s first pharmaceutical sustainability partnership to decarbonise freight of medicines

Alexion and DHL sign Ireland’s first pharmaceutical sustainability partnership to decarbonise freight of medicines

Alexion and DHL sign Ireland’s first pharmaceutical sustainability partnership to decarbonise freight of medicines
Repro Free: Dublin, 30th September 2024 Alexion, AstraZeneca Rare Disease and DHL Global Forwarding Freight today announced a new partnership to commence Ireland's first sustainable fuel deliveries using Hydrogenated Vegetable Oil for the pharmaceutical industry. By converting to HVO fuel, the two companies are aiming to reduce annual Greenhouse Gas from road freight by up to 90% compared to GHG emissions associated with deliveries using diesel. Pictured at Alexion’s Dublin Manufacturing Facility Blanchardstown were Mark Smith, Head of Road Freight, DHL Global Forwarding Ireland, Damien Gannon, Director, Global Logistics, Alexion AstraZeneca Rare Disease, Declan Costelloe, Life Sciences Sector Director, DHL Global Forwarding UK & Ireland, Sylvia Kiely, Vice President, Global Supply Chain and Product Strategy Lead, Alexion AstraZeneca Rare Disease, Maurice Meade, Managing Director, DHL Global Forwarding Freight Ireland, Yvonne Rogers, Road Freight Operations Manager, DHL Global Forwarding Freight Ireland. Picture Jason Clarke

– Partnership aims to reduce annual Greenhouse Gas (GHG) emissions from road freight by up to 90% by converting from diesel to Hydrogenated Vegetable Oil (HVO)

– HVO will be used to deliver medicines to ten countries, with 500 deliveries taking place each year

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free